ClinicalTrials.gg
RecruitingNCT06492252Updated Jul 16, 2026

Speech Motor Learning and Retention (Aim 3)

An interventional study of fMRI and Adaptation in Speech, sponsored by Yale University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-16.

Sponsored by Yale University · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The overall goal of this research is to test a new model of speech motor learning, whose central hypothesis is that learning and retention are associated with plasticity not only in motor areas of the brain but in auditory and somatosensory regions as well. The strategy for the proposed research is to identify individual brain areas that contribute causally to retention by disrupting their activity with transcranial magnetic stimulation (TMS). Investigators will also use functional magnetic resonance imaging (fMRI) which will enable identification of circuit-level activity which predicts either learning or retention of new movements, and hence test the specific contributions of candidate sensory and motor zones. In other studies, investigators will record sensory and motor evoked potentials over the course of learning to determine the temporal order in which individual sensory and cortical motor regions contribute. The goal here is to identify brain areas in which learning-related plasticity occurs first and which among these areas predict subsequent learning.

Read the detailed description

The focus of this registration is Aim 3. Excitability will be assessed. In Aim 3, resting-state fMRI will be interleaved with speech motor adaptation, again using Harvard Sentences. Additional scans and retention tests will be conducted 24 hours later, to assess motor memory consolidation.

The Speech Motor Learning and Retention Master Protocol is NCT06467292.

02

Conditions studied

  • Speech

Browse trials for

Keywords

  • Speech Motor Learning
  • Retention
03

In context

Speech

205 studies on the registry are indexed under Speech; 80 are open to participants now.

This study's planned enrollment of 50 is close to the median of 52 across 141 interventional studies indexed under Speech.

Browse Speech studies →

Lead sponsor

Yale University is the lead sponsor of 1,770 studies on the registry; 294 are open to participants now.

Of its 221 completed or terminated interventional studies of FDA-regulated products, 129 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Fluent English speakers
  • Right-handed
  • Normal hearing
  • No speech disorder or reading disability

Exclusion criteria

Exclusion Criteria:

  • Cardiac pacemaker
  • Aneurysm clip
  • Heart or Vascular clip
  • Prosthetic valve
  • Metal implants
  • Metal in brain, skull, or spinal cord
  • Implanted neurostimulator
  • Medication infusion device
  • Cochlear implant or tinnitus (ringing in ears)
  • Personal and/or family history of epilepsy or other neurological disorders or history of head concussion
  • Psychoactive medications
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Altered auditory feedback + fMRI

    Participants will perform learning tasks then undergo fMRI. This procedure will be repeated on day 2. Functional connectivity patterns between regions that predict learning will be assessed. Participants then leave the laboratory and return 24 hours later to assess retention of learning.

    Device: fMRI · Behavioral: Adaptation

  • Experimental
    Control Condition

    Participants in a control condition who will undergo the same procedures, without altered feedback

    Device: fMRI · Behavioral: Adaptation

Interventions

  • DevicefMRI

    To assess functional connectivity patterns between regions that predict learning.

  • BehavioralAdaptation

    Auditory adaptation in speech

  • BehavioralAdaptation

    Auditory baseline in speech

06

What researchers measure

Primary outcomes

  1. Speech motor learning

    Audapter software will be used to alter the first and second formant frequencies of the spoken words and this is played back to subjects through headphones. Subjects will be tested both with unaltered feedback and with abruptly introduced frequency shifts.The change in the first (F1) and second format frequency (F2) values will be assessed using Praat.

    Time frame: Performance as measured at the end of learning (30 minute session)

  2. Retention of learning

    The retention of adaptation to altered auditory feedback (and relearning) will be quantified in terms of F1 and F2 frequency shifts (relative to pre-training baseline). Larger values indicate more complete relearning or retention.

    Time frame: 24 hours after learning (re-test lasts 30 minutes)

  3. Change in fMRI resting-state connectivity following speech motor learning

    fMRI resting-state connectivity change following speech motor learning. Functional connectivity will be measured between each of the following regions: Heschel's gyrus, posterior superior temporal gyrus, primary and second somatosensory cortex, supramarginal gyrus, inferior frontal gyrus, motor and ventral premotor cortex and supplementary motor area.

    Time frame: baseline and at the end of learning (30 minute session)

  4. fMRI resting-state connectivity measures of motor memory retention

    fMRI resting-state connectivity measures of motor memory retention. Functional connectivity will be measured between each of the following regions: Heschel's gyrus, posterior superior temporal gyrus, primary and second somatosensory cortex, supramarginal gyrus, inferior frontal gyrus, motor and ventral premotor cortex and supplementary motor area.

    Time frame: 24 hours after learning (re-test lasts 30 minutes)

07

Study locations

1 of 1 sites recruiting
  • Yale Child Study Center
    New Haven, Connecticut 06520, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Nov 2028, 30 months after the start.

Of 85 non-industry interventional studies with no phase under Speech, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 65. This study's planned 30 months is below that.

Counting every sponsor, half of 90 studies reached it within 45 months; a quarter within 15 and three quarters within 65.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 1, 2024
First posted
Jul 9, 2024
StartActual
May 4, 2026
Primary completionEst.
Nov 30, 2028
CompletionEst.
May 31, 2029
Last update
Jul 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06492252
Lead sponsor
Yale University
Responsible party
Sponsor
First posted
Jul 9, 2024
Start date
May 4, 2026
Primary completion
Nov 30, 2028 (estimated)
Completion
May 31, 2029 (estimated)
Last update
Jul 16, 2026

Study contacts

Michael Stern
Contact
michael.stern@yale.edu
2038656163
David Ostry
principal investigator · Yale University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion